CliffBio
small molecule

MAGNESIUM SULFATE

MAGNESIUM SULFATE

Loss of exclusivity—loss of exclusivity
CompanyFresenius Kabi →See this company's full patent-cliff portfolio

Drug detail

Brand nameMAGNESIUM SULFATE
Active ingredientMAGNESIUM SULFATE
Strength25GM/50ML (500MG/ML)
Dosage formSOLUTION
RouteINTRAMUSCULAR, INTRAVENOUS
ModalitySmall molecule
FDA approvalJanuary 2016
Marketing statusRX

More from Fresenius Kabi

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.